Shutaro Ishimura

1.6k total citations
19 papers, 1.2k citations indexed

About

Shutaro Ishimura is a scholar working on Molecular Biology, Epidemiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Shutaro Ishimura has authored 19 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Epidemiology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Shutaro Ishimura's work include Peroxisome Proliferator-Activated Receptors (14 papers), Adipokines, Inflammation, and Metabolic Diseases (6 papers) and Eicosanoids and Hypertension Pharmacology (4 papers). Shutaro Ishimura is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (14 papers), Adipokines, Inflammation, and Metabolic Diseases (6 papers) and Eicosanoids and Hypertension Pharmacology (4 papers). Shutaro Ishimura collaborates with scholars based in Japan, United States and Australia. Shutaro Ishimura's co-authors include Tetsuji Miura, Masato Furuhashi, Takahiro Fuseya, Marenao Tanaka, Hideaki Yoshida, Tomohiro Mita, Yuki Watanabe, Kyoko Hoshina, Hideki Ota and Kazuaki Shimamoto and has published in prestigious journals such as PLoS ONE, Scientific Reports and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Shutaro Ishimura

19 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shutaro Ishimura Japan 17 673 326 289 180 173 19 1.2k
Takahiro Fuseya Japan 14 547 0.8× 278 0.9× 235 0.8× 139 0.8× 145 0.8× 20 1.0k
Tianshu Zeng China 22 566 0.8× 423 1.3× 155 0.5× 256 1.4× 506 2.9× 73 1.7k
Despina Tsorotes Australia 12 333 0.5× 100 0.3× 249 0.9× 111 0.6× 222 1.3× 12 890
Niina Sandholm Finland 20 327 0.5× 170 0.5× 156 0.5× 128 0.7× 305 1.8× 57 1.1k
Tlili Barhoumi Saudi Arabia 19 295 0.4× 121 0.4× 451 1.6× 258 1.4× 374 2.2× 48 1.5k
Norihito Moniwa Japan 27 552 0.8× 685 2.1× 810 2.8× 368 2.0× 512 3.0× 59 2.0k
Ling Tu China 19 318 0.5× 139 0.4× 121 0.4× 168 0.9× 275 1.6× 59 1.1k
Xiaohui Li China 25 307 0.5× 295 0.9× 162 0.6× 150 0.8× 115 0.7× 82 2.2k
Aaron Wong United Kingdom 11 427 0.6× 136 0.4× 316 1.1× 157 0.9× 347 2.0× 30 1.1k
Weiqiong Gu China 23 468 0.7× 373 1.1× 287 1.0× 220 1.2× 529 3.1× 63 1.6k

Countries citing papers authored by Shutaro Ishimura

Since Specialization
Citations

This map shows the geographic impact of Shutaro Ishimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shutaro Ishimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shutaro Ishimura more than expected).

Fields of papers citing papers by Shutaro Ishimura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shutaro Ishimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shutaro Ishimura. The network helps show where Shutaro Ishimura may publish in the future.

Co-authorship network of co-authors of Shutaro Ishimura

This figure shows the co-authorship network connecting the top 25 collaborators of Shutaro Ishimura. A scholar is included among the top collaborators of Shutaro Ishimura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shutaro Ishimura. Shutaro Ishimura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Fuseya, Takahiro, Masato Furuhashi, Megumi Matsumoto, et al.. (2017). Ectopic Fatty Acid–Binding Protein 4 Expression in the Vascular Endothelium is Involved in Neointima Formation After Vascular Injury. Journal of the American Heart Association. 6(9). 51 indexed citations
2.
Furuhashi, Masato, Shinya Hiramitsu, Tomohiro Mita, et al.. (2016). Reduction of circulating FABP4 level by treatment with omega-3 fatty acid ethyl esters. Lipids in Health and Disease. 15(1). 5–5. 44 indexed citations
3.
Furuhashi, Masato, Takahiro Fuseya, Masaki Murata, et al.. (2016). Local Production of Fatty Acid–Binding Protein 4 in Epicardial/Perivascular Fat and Macrophages Is Linked to Coronary Atherosclerosis. Arteriosclerosis Thrombosis and Vascular Biology. 36(5). 825–834. 103 indexed citations
4.
Tanaka, Marenao, Masato Furuhashi, Yusuke Okazaki, et al.. (2015). Ectopic Expression of Fatty Acid-Binding Protein 4 in the Glomerulus Is Associated with Proteinuria and Renal Dysfunction. Nephron Clinical Practice. 128(3-4). 345–351. 41 indexed citations
5.
Furuhashi, Masato, Tomohiro Mita, Norihito Moniwa, et al.. (2015). Angiotensin II receptor blockers decrease serum concentration of fatty acid-binding protein 4 in patients with hypertension. Hypertension Research. 38(4). 252–259. 44 indexed citations
6.
Furuhashi, Masato, Shinya Hiramitsu, Tomohiro Mita, et al.. (2015). Reduction of serum FABP4 level by sitagliptin, a DPP-4 inhibitor, in patients with type 2 diabetes mellitus. Journal of Lipid Research. 56(12). 2372–2380. 45 indexed citations
7.
Yano, Toshiyuki, Shutaro Ishimura, Masayuki Koyama, et al.. (2014). Cardiac tamponade leading to the diagnosis of eosinophilic granulomatosis with polyangiitis (Churg−Strauss syndrome): a case report and review of the literature. Heart and Vessels. 30(6). 841–844. 13 indexed citations
8.
Furuhashi, Masato, Norihito Moniwa, Takahiro Fuseya, et al.. (2014). Urinary Angiotensin-Converting Enzyme 2 in Hypertensive Patients May Be Increased by Olmesartan, an Angiotensin II Receptor Blocker. American Journal of Hypertension. 28(1). 15–21. 194 indexed citations
9.
Ishimura, Shutaro, Masato Furuhashi, Tomohiro Mita, et al.. (2014). Reduction of endoplasmic reticulum stress inhibits neointima formation after vascular injury. Scientific Reports. 4(1). 6943–6943. 30 indexed citations
10.
Fuseya, Takahiro, Masato Furuhashi, Satoshi Yuda, et al.. (2014). Elevation of circulating fatty acid-binding protein 4 is independently associated with left ventricular diastolic dysfunction in a general population. Cardiovascular Diabetology. 13(1). 126–126. 70 indexed citations
11.
Koyama, Masayuki, Masato Furuhashi, Shutaro Ishimura, et al.. (2014). Reduction of endoplasmic reticulum stress by 4-phenylbutyric acid prevents the development of hypoxia-induced pulmonary arterial hypertension. American Journal of Physiology-Heart and Circulatory Physiology. 306(9). H1314–H1323. 82 indexed citations
12.
Okazaki, Yusuke, Masato Furuhashi, Marenao Tanaka, et al.. (2014). Urinary Excretion of Fatty Acid-Binding Protein 4 is Associated with Albuminuria and Renal Dysfunction. PLoS ONE. 9(12). e115429–e115429. 36 indexed citations
13.
Mita, Tomohiro, Masato Furuhashi, Shinya Hiramitsu, et al.. (2014). FABP4 is secreted from adipocytes by adenyl cyclase-PKA- and guanylyl cyclase-PKG-dependent lipolytic mechanisms. Obesity. 23(2). 359–367. 82 indexed citations
14.
Ishimura, Shutaro, Masato Furuhashi, Yuki Watanabe, et al.. (2013). Circulating Levels of Fatty Acid-Binding Protein Family and Metabolic Phenotype in the General Population. PLoS ONE. 8(11). e81318–e81318. 118 indexed citations
15.
Ota, Hideki, Masato Furuhashi, Shutaro Ishimura, et al.. (2012). Elevation of Fatty Acid-Binding Protein 4 Is Predisposed by Family History of Hypertension and Contributes to Blood Pressure Elevation. American Journal of Hypertension. 25(10). 1124–1130. 84 indexed citations
16.
Fuseya, Takahiro, Masato Furuhashi, Hideki Ota, et al.. (2012). 197 ELEVATION OF PLASMA FATTY ACID-BINDING PROTEIN 4 LEVEL CONTRIBUTES TO BLOOD PRESSURE ELEVATION AND INSULIN RESISTANCE IN ESSENTIAL HYPERTENSION. Journal of Hypertension. 30(Supplement 1). e58–e59. 1 indexed citations
17.
Furuhashi, Masato, Shutaro Ishimura, Hideki Ota, et al.. (2011). Serum Fatty Acid-Binding Protein 4 Is a Predictor of Cardiovascular Events in End-Stage Renal Disease. PLoS ONE. 6(11). e27356–e27356. 85 indexed citations
18.
Furuhashi, Masato, Shutaro Ishimura, Hideki Ota, & Tetsuji Miura. (2011). Lipid Chaperones and Metabolic Inflammation. International Journal of Inflammation. 2011. 1–12. 89 indexed citations
19.
Tanaka, Marenao, Hideaki Yoshida, Masato Furuhashi, et al.. (2011). Deterioration of Renal Function by Chronic Heart Failure is Associated with Congestion and Oxidative Stress in the Tubulointerstitium. Internal Medicine. 50(23). 2877–2887. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takahiro Fuseya Breakdown of academic impact, for papers by Tianshu Zeng Breakdown of academic impact, for papers by Despina Tsorotes Breakdown of academic impact, for papers by Niina Sandholm Breakdown of academic impact, for papers by Tlili Barhoumi Breakdown of academic impact, for papers by Norihito Moniwa Breakdown of academic impact, for papers by Ling Tu Breakdown of academic impact, for papers by Xiaohui Li Breakdown of academic impact, for papers by Aaron Wong Breakdown of academic impact, for papers by Weiqiong Gu
Rankless by CCL
2026